CA2417828A1 - Tartrate salts of thiazolidinedione derivative - Google Patents

Tartrate salts of thiazolidinedione derivative Download PDF

Info

Publication number
CA2417828A1
CA2417828A1 CA002417828A CA2417828A CA2417828A1 CA 2417828 A1 CA2417828 A1 CA 2417828A1 CA 002417828 A CA002417828 A CA 002417828A CA 2417828 A CA2417828 A CA 2417828A CA 2417828 A1 CA2417828 A1 CA 2417828A1
Authority
CA
Canada
Prior art keywords
meso
tartrate
solvate
accordance
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002417828A
Other languages
English (en)
French (fr)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2417828A1 publication Critical patent/CA2417828A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
CA002417828A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative Abandoned CA2417828A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0019226.0 2000-08-04
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
CA2417828A1 true CA2417828A1 (en) 2002-02-14

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002417828A Abandoned CA2417828A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Country Status (23)

Country Link
EP (1) EP1307448A1 (ja)
JP (1) JP2004505971A (ja)
KR (1) KR20030022356A (ja)
CN (1) CN1458930A (ja)
AP (1) AP2003002737A0 (ja)
AU (1) AU2001276508A1 (ja)
BG (1) BG107605A (ja)
BR (1) BR0112984A (ja)
CA (1) CA2417828A1 (ja)
CZ (1) CZ2003314A3 (ja)
EA (1) EA200300231A1 (ja)
EC (1) ECSP034468A (ja)
GB (1) GB0019226D0 (ja)
HU (1) HUP0300770A2 (ja)
IL (1) IL154277A0 (ja)
MA (1) MA25830A1 (ja)
MX (1) MXPA03001086A (ja)
NO (1) NO20030508L (ja)
OA (1) OA12355A (ja)
PL (1) PL360702A1 (ja)
SK (1) SK1452003A3 (ja)
WO (1) WO2002012233A1 (ja)
ZA (1) ZA200300962B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MA25830A1 (fr) 2003-07-01
KR20030022356A (ko) 2003-03-15
ZA200300962B (en) 2003-10-29
NO20030508L (no) 2003-03-20
BG107605A (bg) 2003-09-30
CN1458930A (zh) 2003-11-26
EP1307448A1 (en) 2003-05-07
GB0019226D0 (en) 2000-09-27
WO2002012233A1 (en) 2002-02-14
AU2001276508A1 (en) 2002-02-18
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
EA200300231A1 (ru) 2003-06-26
OA12355A (en) 2004-03-19
HUP0300770A2 (hu) 2003-11-28
ECSP034468A (es) 2003-03-31
JP2004505971A (ja) 2004-02-26
IL154277A0 (en) 2003-09-17
PL360702A1 (en) 2004-09-20
BR0112984A (pt) 2003-06-10
NO20030508D0 (no) 2003-01-31
AP2003002737A0 (en) 2003-03-31
SK1452003A3 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
EP1349855B1 (en) 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
CA2417828A1 (en) Tartrate salts of thiazolidinedione derivative
US20040014791A1 (en) Thiazolidinedione derivative and its use as antidiabetic
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
EP1795531A1 (en) A thiazolidinedione derivative and its use as antidiabetic
WO2003050111A1 (en) Toluenesulfonate salts of a thiazolidinedione derivative
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic

Legal Events

Date Code Title Description
FZDE Discontinued